- Home
- VSTE vs IKNA Comparison
VSTE vs IKNA Comparison
Compare VSTE & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- IKNA
- Stock Information
- Founded
- VSTE 2009
- IKNA 2016
- Country
- VSTE Australia
- IKNA United States
- Employees
- VSTE N/A
- IKNA N/A
- Industry
- VSTE
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- VSTE
- IKNA Health Care
- Exchange
- VSTE Nasdaq
- IKNA Nasdaq
- Market Cap
- VSTE 30.0M
- IKNA 83.0M
- IPO Year
- VSTE N/A
- IKNA 2021
- Fundamental
- Price
- VSTE $2.42
- IKNA $1.68
- Analyst Decision
- VSTE
- IKNA Buy
- Analyst Count
- VSTE 0
- IKNA 2
- Target Price
- VSTE N/A
- IKNA $3.00
- AVG Volume (30 Days)
- VSTE 14.1K
- IKNA 41.6K
- Earning Date
- VSTE 01-01-0001
- IKNA 11-07-2024
- Dividend Yield
- VSTE N/A
- IKNA N/A
- EPS Growth
- VSTE N/A
- IKNA N/A
- EPS
- VSTE N/A
- IKNA N/A
- Revenue
- VSTE $342,000.00
- IKNA $1,844,000.00
- Revenue This Year
- VSTE N/A
- IKNA N/A
- Revenue Next Year
- VSTE N/A
- IKNA N/A
- P/E Ratio
- VSTE N/A
- IKNA N/A
- Revenue Growth
- VSTE N/A
- IKNA N/A
- 52 Week Low
- VSTE $0.83
- IKNA $1.02
- 52 Week High
- VSTE $12.00
- IKNA $4.63
- Technical
- Relative Strength Index (RSI)
- VSTE 55.09
- IKNA 51.57
- Support Level
- VSTE $0.83
- IKNA $1.68
- Resistance Level
- VSTE $1.09
- IKNA $1.78
- Average True Range (ATR)
- VSTE 0.10
- IKNA 0.04
- MACD
- VSTE 0.03
- IKNA 0.00
- Stochastic Oscillator
- VSTE 92.08
- IKNA 36.36
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.